• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗旅游的风险:携带 NDM-1 耐药基因的大肠杆菌导致一名医疗游客发热性中性粒细胞减少症。

The perils of medical tourism: NDM-1-positive Escherichia coli causing febrile neutropenia in a medical tourist.

机构信息

Department of Haematology-Oncology, National Univeristy Hospital, 1E Lower Kent Ridge Road, NUHS Tower Block Level 7, Singapore 119228.

出版信息

Singapore Med J. 2011 Apr;52(4):299-302.

PMID:21552793
Abstract

NDM-1 is a new metallo-beta-lactamase that readily hydrolyses carbapenems, penicillins and cephalosporins. Its rising incidence has been reported in many countries around the world, with many cases linked to a possible origin from the Indian subcontinent. Due to the lack of effective antibiotic regimes to treat these infections, the increased prevalence of NDM-1 is alarming. We describe a case of NDM-1 infection in an immunocompromised foreign patient, and discuss its implications.

摘要

NDM-1 是一种新型的金属β-内酰胺酶,能够轻易地水解碳青霉烯类、青霉素类和头孢菌素类抗生素。这种酶在世界各地的许多国家都有出现,且有许多案例都可能与印度次大陆有关。由于缺乏有效的抗生素治疗方案,这种酶的广泛传播令人担忧。我们报告了一例免疫功能低下的外国患者感染 NDM-1 的病例,并对其进行了讨论。

相似文献

1
The perils of medical tourism: NDM-1-positive Escherichia coli causing febrile neutropenia in a medical tourist.医疗旅游的风险:携带 NDM-1 耐药基因的大肠杆菌导致一名医疗游客发热性中性粒细胞减少症。
Singapore Med J. 2011 Apr;52(4):299-302.
2
New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised.肠杆菌科细菌中的新德里金属β-内酰胺酶(NDM-1):碳青霉烯类药物的治疗选择受到影响。
J Assoc Physicians India. 2010 Mar;58:147-9.
3
Febrile neutropenia: are you up to date?发热性中性粒细胞减少症:你了解最新情况吗?
Can Oncol Nurs J. 2003 Fall;13(4):246-9.
4
[Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].[循证医学概念在发热性中性粒细胞减少症治疗证据中的应用]
Enferm Infecc Microbiol Clin. 1999;17 Suppl 2:95-102.
5
Current challenges in antimicrobial chemotherapy: the impact of extended-spectrum beta-lactamases and metallo-beta-lactamases on the treatment of resistant Gram-negative pathogens.抗菌化疗当前面临的挑战:超广谱β-内酰胺酶和金属β-内酰胺酶对耐药革兰氏阴性病原体治疗的影响。
Curr Opin Pharmacol. 2005 Oct;5(5):452-8. doi: 10.1016/j.coph.2005.04.013.
6
Perspectives for the management of febrile neutropenic patients with cancer in the 21st century.21世纪癌症发热性中性粒细胞减少患者的管理前景
Cancer. 2005 Mar 15;103(6):1103-13. doi: 10.1002/cncr.20890.
7
Emerging carbapenem resistance in the context of a new metallo-beta-lactamase (NDM-1).在一种新型金属β-内酰胺酶(NDM-1)背景下新出现的碳青霉烯类耐药性
Natl Med J India. 2010 Sep-Oct;23(5):261-2.
8
Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.产超广谱β-内酰胺酶的大肠埃希菌和肺炎克雷伯菌:感染的危险因素及耐药性对预后的影响
J Assoc Physicians India. 2010 Dec;58 Suppl:41-4.
9
Risk factors and outcomes of bloodstream infections with metallo-beta-lactamase-producing Acinetobacter.产金属β-内酰胺酶不动杆菌血流感染的危险因素及结局
Scand J Infect Dis. 2008;40(3):234-40. doi: 10.1080/00365540701633004. Epub 2007 Sep 7.
10
Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.通过改变抗菌药物使用政策控制儿童医院中产超广谱β-内酰胺酶的大肠埃希菌和肺炎克雷伯菌
J Antimicrob Chemother. 2007 Sep;60(3):629-37. doi: 10.1093/jac/dkm225. Epub 2007 Jun 27.

引用本文的文献

1
Understanding and comparing the medical tourism cancer patient with the locally managed patient: A case control study.理解和比较医疗旅游癌症患者与本地管理患者:一项病例对照研究。
PLoS One. 2022 Sep 21;17(9):e0273162. doi: 10.1371/journal.pone.0273162. eCollection 2022.
2
Travel-Related Antimicrobial Resistance: A Systematic Review.与旅行相关的抗菌药物耐药性:一项系统综述。
Trop Med Infect Dis. 2021 Jan 16;6(1):11. doi: 10.3390/tropicalmed6010011.
3
Antibiotic Resistance in Enterobacteriaceae from Surface Waters in Urban Brazil Highlights the Risks of Poor Sanitation.
巴西城市地表水肠杆菌科的抗生素耐药性凸显了卫生条件差带来的风险。
Am J Trop Med Hyg. 2019 Jun;100(6):1369-1377. doi: 10.4269/ajtmh.18-0726.
4
Were all carbapenemases created equal? Treatment of NDM-producing extensively drug-resistant Enterobacteriaceae: a case report and literature review.所有碳青霉烯酶都是一样的吗?产新德里金属β-内酰胺酶(NDM)的广泛耐药肠杆菌科的治疗:病例报告和文献复习。
Infection. 2018 Feb;46(1):1-13. doi: 10.1007/s15010-017-1070-8. Epub 2017 Sep 15.
5
Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia.南亚和东南亚地区耐碳青霉烯类鲍曼不动杆菌和肠杆菌科细菌
Clin Microbiol Rev. 2017 Jan;30(1):1-22. doi: 10.1128/CMR.masthead.30-1. Epub 2016 Oct 19.
6
The Threat and Response to Infectious Diseases (Revised).传染病的威胁与应对(修订版)。
Microb Ecol. 2018 Jul;76(1):19-36. doi: 10.1007/s00248-016-0806-9. Epub 2016 Aug 1.
7
Global Access to Health Care and Well-Being: A Place for Policy and Science.全球医疗保健与福祉:政策与科学的作用
Front Public Health. 2016 Jun 28;4:129. doi: 10.3389/fpubh.2016.00129. eCollection 2016.
8
Impact of the New Delhi metallo-beta-lactamase on beta-lactam antibiotics.新德里金属β-内酰胺酶对β-内酰胺类抗生素的影响。
Infect Drug Resist. 2015 Aug 24;8:297-309. doi: 10.2147/IDR.S39186. eCollection 2015.
9
In vivo efficacy of human simulated regimens of carbapenems and comparator agents against NDM-1-producing Enterobacteriaceae.碳青霉烯类药物及对照药物的人体模拟给药方案对产NDM-1肠杆菌科细菌的体内疗效。
Antimicrob Agents Chemother. 2014;58(3):1671-7. doi: 10.1128/AAC.01946-13. Epub 2013 Dec 30.
10
Efficacy of humanized carbapenem exposures against New Delhi metallo-β-lactamase (NDM-1)-producing enterobacteriaceae in a murine infection model.人用碳青霉烯类药物暴露对产新德里金属β-内酰胺酶(NDM-1)肠杆菌科在小鼠感染模型中的疗效。
Antimicrob Agents Chemother. 2013 Aug;57(8):3936-40. doi: 10.1128/AAC.00708-13. Epub 2013 Jun 3.